B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos,

J. Gonçalves-Pereira, A. Martins, P. Póvoa

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

J. Gonçalves-Pereira, A. Martins, P. Póvoa

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations D. Andes, W.A. Craig Clinical Microbiology.

Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility Javier Garau, Walter Wilson,

Oral versus intravenous therapy in the treatment of systemic mycosis

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

R. Bitterman, M. Paul, D. Polak, Y. Geffen

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

W.A. Craig Clinical Microbiology and Infection

The practice of travel medicine in Europe

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Antibacterial drug discovery in the 21st century

The role of antimalarial treatment in the elimination of malaria

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A

A.P. Underwood, J. Green Clinical Microbiology and Infection

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

W. Eugene Sanders, Christine C. Sanders

Can pharmacokinetic–pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance? P. Courvalin Clinical Microbiology and.

Overview of cefixime use in community-acquired infections

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Are we losing the fight against malaria one more time?

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Relationship between pharmacokinetics and pharmacodynamics of b-lactams and outcome B. Sádaba, J.R. Azanza, M.A. Campanero, E. García-Quetglas Clinical Microbiology and Infection Volume 10, Issue 11, Pages 990-998 (November 2004) DOI: 10.1111/j.1469-0691.2004.00994.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Illustration of the segments AUCt1–T and AUCT–(t2 + T). Clinical Microbiology and Infection 2004 10, 990-998DOI: (10.1111/j.1469-0691.2004.00994.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 MIC, trough concentration and ratio in relation to clinical outcome (the horizontal line represents the unit value). Clinical Microbiology and Infection 2004 10, 990-998DOI: (10.1111/j.1469-0691.2004.00994.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions